| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.2349/BIIJ.4.3.E40 |
| P724 | Internet Archive ID | pubmed-PMC3097728 |
| P932 | PMC publication ID | 3097728 |
| P698 | PubMed publication ID | 21611006 |
| P5875 | ResearchGate publication ID | 51163762 |
| P2093 | author name string | D E Heron | |
| J E Shogan | |||
| J W Mucenski | |||
| P2860 | cites work | Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility | Q28239961 |
| New anticoagulants for treatment of venous thromboembolism | Q28269942 | ||
| A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer | Q28297827 | ||
| Evaluation of recurrent squamous cell carcinoma of the head and neck with FDG positron emission tomography | Q32000606 | ||
| Novel thrombopoietic agents: a review of their use in idiopathic thrombocytopenic purpura | Q33379498 | ||
| Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer | Q33436217 | ||
| Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new? | Q34382797 | ||
| Anthracycline cardiotoxicity: from bench to bedside | Q34477415 | ||
| 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline | Q34523108 | ||
| Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing | Q71571905 | ||
| The influence of respiration induced motion of the kidneys on the accuracy of radiotherapy treatment planning, a magnetic resonance imaging study | Q72421981 | ||
| Respiration-induced motion of the kidneys in whole abdominal radiotherapy: implications for treatment planning and late toxicity | Q73301138 | ||
| Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies | Q73308604 | ||
| Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation | Q74410489 | ||
| Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies | Q74419156 | ||
| Radiation therapy treatment optimization. Introduction | Q77299046 | ||
| Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation | Q77891871 | ||
| Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial | Q77937719 | ||
| A precision cobalt 60 unit for fixed field and rotation therapy | Q78459626 | ||
| Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas: preliminary clinical experience | Q78790836 | ||
| Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose–volume histograms☆ | Q79124290 | ||
| Molecule of the month. Elesclomol and obatoclax mesylate | Q81017820 | ||
| Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer | Q81378656 | ||
| Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression | Q81888873 | ||
| New Bcr-Abl inhibitors in chronic myeloid leukemia: keeping resistance in check | Q94700473 | ||
| The potential of proteasome inhibitors in cancer therapy | Q94700475 | ||
| Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer | Q34563697 | ||
| Protection of salivary function by intensity-modulated radiation therapy in patients with head and neck cancer | Q34578881 | ||
| Current and emerging treatment options in chronic myeloid leukemia | Q34618814 | ||
| Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline | Q34705240 | ||
| Intensity-modulated radiation therapy for prostate cancer | Q34739848 | ||
| Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer | Q34739888 | ||
| Commercialized multigene predictors of clinical outcome for breast cancer. | Q34783293 | ||
| New potentials of radiotherapy in non-small cell lung cancer: stereotactic therapy and IMRT. | Q35060474 | ||
| Clinical development of anti-RANKL therapy | Q35901092 | ||
| Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer. | Q36445825 | ||
| ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes | Q36601020 | ||
| EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update | Q36689459 | ||
| International Society of Geriatric Oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patients. | Q36720231 | ||
| Trastuzumab: triumphs and tribulations | Q36832109 | ||
| Lapatinib in breast cancer | Q36860184 | ||
| Evolving role of monoclonal antibodies in the treatment of chronic lymphocytic leukemia | Q36985872 | ||
| Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology | Q37022459 | ||
| Antiemetics: an update and the MASCC guidelines applied in clinical practice | Q37039597 | ||
| Exploiting signal transduction pathways in acute myelogenous leukemia | Q37039628 | ||
| Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies | Q37047728 | ||
| Cetuximab, its clinical use and future perspectives | Q37050881 | ||
| A decade of rituximab: improving survival outcomes in non-Hodgkin's lymphoma | Q37054400 | ||
| U.S. Food and Drug Administration approval: panitumumab for epidermal growth factor receptor-expressing metastatic colorectal carcinoma with progression following fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens | Q37100603 | ||
| Epothilones: clinical update and future directions. | Q37160242 | ||
| A diagnostic-quality electronic portal imaging system | Q39368426 | ||
| Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head | Q44286067 | ||
| American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer | Q44578291 | ||
| Phase I dose escalation and pharmacokinetic study of lapatinib in combination with trastuzumab in patients with advanced ErbB2-positive breast cancer | Q46587289 | ||
| Erlotinib for advanced non-small-cell lung cancer in the elderly: an analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21. | Q46604163 | ||
| Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome | Q46915684 | ||
| Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas | Q48561977 | ||
| Role of radiotherapy in cancer control in low-income and middle-income countries | Q50108203 | ||
| Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. | Q51687498 | ||
| A comprehensive three-dimensional radiation treatment planning system. | Q52553785 | ||
| Quantitative status of resources for radiation therapy in Asia and Pacific region. | Q53324681 | ||
| IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk. | Q53610475 | ||
| Novel therapies targeting the immune system: CTLA4 blockade with tremelimumab (CP-675,206), a fully human monoclonal antibody | Q56900749 | ||
| A radiographic and tomographic imaging system integrated into a medical linear accelerator for localization of bone and soft-tissue targets | Q61903143 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| P304 | page(s) | e40 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | Biomedical Imaging and Intervention Journal | Q4915112 |
| P1476 | title | Innovations in chemotherapy and radiation therapy: Implications and opportunities for the Asia-Pacific Rim. | |
| P478 | volume | 4 |
Search more.